Enlaces de acceso:
CONTENIDO
Destacados
Inmunidad Celular y Genética del huésped
Publicaciones
-
Differential prevalence of the HLA-C -- 35 CC genotype among viremic long term non-progressor and...
Immunobiology. 2012 Sep;217(9):889-94. doi: 10.1016/j.imbio.2011.12.012. Epub 2012 Jan 8
Susceptibility to HIV infection and disease progression are complex traits modulated by environmental and genetic factors,...
-
Uncommon Pathways of Immune Escape Attenuate HIV-1 Integrase Replication Capacity
J. Virol. June 2012 vol. 86 no. 12 6913-6923
An attenuation of the HIV-1 replication capacity (RC) has been observed for immune-mediated escape mutations in Gag restricted by...
-
HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32
Immunobiology(2012). DOI:10.1016/j.imbio.2012.06.012.
Homozygosity for a 32bp deletion in CCR5 (CCR5-Δ32/Δ32) is associated with strong resistance against HIV-1 infection. Several...
-
Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune...
PLoS Pathog. 2012 Mar;8(3):e1002529. Epub 2012 Mar 8
Deep sequencing technologies have the potential to transform the study of highly variable viral pathogens by providing a rapid...
Seminarios y Congresos
AIDS Vaccine 2013 - BARCELONA
07.10.13bb AIDS Vaccine is the largest and most diverse international meeting of researchers, advocates, clinicians, private sector partners and...
- 03.04.13 - 03.04.13
Scientific Coffee: HIV Vaccine Research (Seminari d'Investigació a l'IGTP)
Scientific Coffee: HIV Vaccine Research. Seminaris d'Investigació a l'Institut d'Investigació...
Más información - 19.03.13 - 19.03.13
[IrsiCaixa Seminar] Will it be possible to live without cART? Natural and induced control of HIV-infection
IrsiCaixa Seminar: Will it be possible to live without cART? Natural and induced control of HIV-infection
Lecturer: Asier Sáez-Cirión.
Más información
Proyectos
CUTHIVAC Cutaneous HIV Vaccination
Entidad finanzadora: European Comission
Entidad(es) participant(es): Universite Pierre et Marie Curie, University of Regensburg, FIT Biotech Oy Ltd, CHARITE, St George’s University of London, MRC Medical Research Council, IMPACTA, Centre National de la Recherche Scientifique, INSERM, Instituto Nacional de Saúde, GENEART AG, NOVAMEN
Investigador(s) responsable(s): Christian Brander
